trending Market Intelligence /marketintelligence/en/news-insights/trending/vKFgLMQ8zkDQYRm_SYa0vg2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

In This List

Assembly Biosciences prices $125M stock, warrants offering to fund research

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

The Market Intelligence Platform

Assembly Biosciences prices $125M stock, warrants offering to fund research

Assembly Biosciences Inc. priced a common stock and warrants offering to raise about $125 million in gross proceeds.

The Carmel, Ind.-based biotechnology company priced the public offering of 5,151,515 common shares at $16.50 apiece.

In addition, Assembly is also offering pre-funded warrants to a certain existing investor to buy up to 2,424,242 common shares at $16.499 per pre-funded warrant.

Jefferies LLC, SVB Leerink LLC and William Blair & Co. LLC are serving as joint book-running managers, while Mizuho Securities USA LLC and Robert W. Baird & Co. Inc. are acting as co-managers for the offering.

The company granted the underwriters a 30-day option to buy up to an additional 1,136,363 shares for $16.50 each.

Assembly plans to use the net proceeds from the sale of the common stock to fund clinical trials, nonclinical studies, research and development and for general corporate purposes.

The offering is expected to close around Dec. 16, subject to customary closing conditions.